Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells

[1]  A. Kawiak,et al.  Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy , 2022, Cancers.

[2]  A. Welm,et al.  An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer , 2021, Breast Cancer Research.

[3]  A. Letai,et al.  ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins , 2021, Cells.

[4]  Zhi Chen The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases , 2021, Journal of Molecular Medicine.

[5]  J. Zeng,et al.  A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis , 2021, Cancer research and treatment.

[6]  Zhi Chen,et al.  The Monocyte-Derived Exosomal CLMAT3 Activates the CtBP2-p300-NF-κB Transcriptional Complex to Induce Proinflammatory Cytokines in ALI , 2020, Molecular therapy. Nucleic acids.

[7]  Matteo Lambrughi,et al.  Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level , 2019, PLoS Comput. Biol..

[8]  H. Salehiniya,et al.  Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.

[9]  Suxia Han,et al.  Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway , 2019, Front. Oncol..

[10]  N. Bowden,et al.  BCL-2 family isoforms in apoptosis and cancer , 2019, Cell Death & Disease.

[11]  S. Tait,et al.  Targeting BCL-2 regulated apoptosis in cancer , 2018, Open Biology.

[12]  C. Duvall,et al.  Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers , 2018, Cell Death & Disease.

[13]  G. Kalna,et al.  MCL-1 is a prognostic indicator and drug target in breast cancer , 2018, Cell Death & Disease.

[14]  Carmela Fimognari,et al.  Broad targeting of resistance to apoptosis in cancer , 2015, Seminars in cancer biology.

[15]  R. Cook,et al.  Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? , 2015, Oncotarget.

[16]  O. Yersal,et al.  Biological subtypes of breast cancer: Prognostic and therapeutic implications. , 2014, World journal of clinical oncology.

[17]  E. Henson,et al.  Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells , 2014, PloS one.

[18]  Xinmin Zhou,et al.  Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells , 2014, BMC Cancer.

[19]  Ö. Türeci,et al.  NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells , 2013, BMC Cancer.

[20]  Zhongyu Yuan,et al.  Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis. , 2013, Current oncology.

[21]  S. Tait,et al.  Multiple functions of BCL-2 family proteins. , 2013, Cold Spring Harbor perspectives in biology.

[22]  V. Tam,et al.  A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein. , 2012, Carcinogenesis.

[23]  B. O’Malley,et al.  Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. , 2011, Molecular endocrinology.

[24]  F M Blows,et al.  BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received , 2010, British Journal of Cancer.

[25]  A. Onitilo,et al.  Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.

[26]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[27]  A. Wellstein,et al.  Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway , 2003, Oncogene.

[28]  S. Catz,et al.  Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer , 2001, Oncogene.

[29]  W. Zong,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .

[30]  J. G. McGuire What in the world? , 1996, The Journal of school health.

[31]  C Gélinas,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. , 1999, Genes & development.

[32]  L. Leung,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0706 Paradoxical regulation of Bcl-2 family proteins by , 2022 .